Conestoga Capital Advisors’s Vericel Corp VCEL Stock Holding History
Bought
Maintained
Sold
Other funds holding VCEL
CAM
GKIM
SCM
GCM
Conestoga Capital Advisors's VCEL Position: Q2 2026 in Review
Conestoga Capital Advisors reduced its Vericel Corp (VCEL) stake by 15% in Q2 2026, selling an estimated $13.7M and leaving 2,083,832 shares worth $92.7M. The position accounts for 2.02% of the portfolio, ranked #21.
Conestoga Capital Advisors first reported a position in VCEL in Q3 2019 and has held it in 28 quarters since. The position peaked at $121M in Q1 2024. 319 funds tracked by Wall St. Rank hold VCEL as of Q2 2026.
- Conestoga Capital Advisors held 2,083,832 shares of Vericel Corp worth $92.7M as of Q2 2026.
- Conestoga Capital Advisors sold 379,480 Vericel Corp shares in Q2 2026, an estimated $13.7M.
- Vericel Corp made up 2.02% of Conestoga Capital Advisors's portfolio in Q2 2026, its #21 holding.
- Conestoga Capital Advisors first reported a position in Vericel Corp in Q3 2019 and has held it in 28 quarters since.
- Conestoga Capital Advisors's Vericel Corp position peaked at $121M in Q1 2024.
- 319 funds tracked by Wall St. Rank held Vericel Corp as of Q2 2026.
Based on Conestoga Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.